Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
137 items
An occupational therapist at Thomas Jefferson University works with a patient who has low vision. Credit: Thomas Jefferson University.

Rehabilitation helps prevent depression from age-related vision loss

Depression is a common risk for people who have lost their vision from age-related macular degeneration (AMD), but a new study shows that a type of rehabilitation therapy can cut this risk in half.
From left to right: Drs. Miriam and Frederick Ferris, Dr. Emily Chew, Keller Johnson-Thompson, who is the great-grandniece of Helen Keller, and Dr. Robert Murphy, who is Dr. Chew's husband.

NEI's Ferris and Chew receive Helen Keller Prize for Vision Research

Frederick L. Ferris III, M.D., and Emily Y. Chew, M.D., who are director and deputy director of the NEI Division of Epidemiology and Clinical Applications, have received the Helen Keller Prize for Vision Research.
Dr. Krzysztof Palczewski

Translational research through teamwork

Imagine you are building a house. You would need a team of specialists, including an architect, a general contractor, carpenters, an electrician, a plumber and many others.
Two boys smile at camera. Dark spot in center of image represents vision loss from AMD.

Three studies point to same risk gene for age-related macular degeneration

Three studies reported in Nature Genetics have converged on the same gene as a rare, but powerful risk factor for age-related macular degeneration (AMD), a common cause of vision loss in older people.
2 young boys hold balls and smile at the camera

NIH study provides clarity on supplements for protection against blinding eye disease

Adding omega-3 fatty acids did not improve a combination of nutritional supplements commonly recommended for treating age-related macular degeneration (AMD), a major cause of vision loss among older Americans.
National Eye Institute logo.

Targeting cholesterol buildup in eye may slow age-related vision loss

Targeting cholesterol metabolism in the eye might help prevent a severe form of age-related macular degeneration (AMD), one of the most common causes of blindness in older Americans.
National Eye Institute logo.

Seven genetic risk factors found to be associated with common eye disorder

An international group of researchers has discovered seven new regions of the human genome—called loci-that are associated with increased risk of age-related macular degeneration (AMD), a leading cause of blindness.
Two boys smile at camera. Dark spot in center of image represents vision loss from AMD.

NIH study suggests immune system could play a central role in AMD

Changes in how genes in the immune system function may result in age-related macular degeneration (AMD), the leading cause of visual impairment in older adults, based on preliminary research conducted by National Institutes of Health (NIH) investigators.
National Eye Institute logo.

Retinal Device Restores Sight in Mice

Researchers have developed a new prosthetic technique that can restore vision to blind mice. The approach could potentially be further developed to improve sight in blind people.
National Eye Institute logo.

Avastin and Lucentis are equivalent in treating age-related macular degeneration

At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD).